Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Jittiporn Chaisaingmongkol, Anuradha Budhu, Hien Dang, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 57-70.e3
Open Access | Times Cited: 368

Showing 1-25 of 368 citing articles:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma, Miaojun Han, Bernd Heinrich, et al.
Science (2018) Vol. 360, Iss. 6391
Open Access | Times Cited: 1180
Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Qiang Gao, Hongwen Zhu, Liangqing Dong, et al.
Cell (2019) Vol. 179, Iss. 2, pp. 561-577.e22
Open Access | Times Cited: 809
Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
Lichun Ma, Maria O. Hernandez, Yongmei Zhao, et al.
Cancer Cell (2019) Vol. 36, Iss. 4, pp. 418-430.e6
Open Access | Times Cited: 617
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 503
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou, Jean–Charles Nault
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 215-229
Open Access | Times Cited: 436
Necroptosis microenvironment directs lineage commitment in liver cancer
Marco Seehawer, Florian Heinzmann, Luana D’Artista, et al.
Nature (2018) Vol. 562, Iss. 7725, pp. 69-75
Open Access | Times Cited: 349
Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Hongping Zheng, Yotsawat Pomyen, Maria O. Hernandez, et al.
Hepatology (2018) Vol. 68, Iss. 1, pp. 127-140
Open Access | Times Cited: 296
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
Jiajie Hou, He Zhang, Jun Liu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 283
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Alphonse E. Sirica, Gregory J. Gores, John D. Groopman, et al.
Hepatology (2018) Vol. 69, Iss. 4, pp. 1803-1815
Open Access | Times Cited: 273
Anatomical, histomorphological and molecular classification of cholangiocarcinoma
Timothy J. Kendall, Joanne Verheij, Eugenio Gaudio, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 7-18
Open Access | Times Cited: 267
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Ruidong Xue, Lu Chen, Chong Zhang, et al.
Cancer Cell (2019) Vol. 35, Iss. 6, pp. 932-947.e8
Open Access | Times Cited: 236
Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Lichun Ma, Limin Wang, Subreen A. Khatib, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1397-1408
Open Access | Times Cited: 236
Comprehensive molecular and immunological characterization of hepatocellular carcinoma
Shu Shimada, Kaoru Mogushi, Yoshimitsu Akiyama, et al.
EBioMedicine (2018) Vol. 40, pp. 457-470
Open Access | Times Cited: 224
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Robert Montal, Daniela Sia, Carla Montironi, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 315-327
Open Access | Times Cited: 219
Metabolic rearrangements in primary liver cancers: cause and consequences
Letizia Satriano, Monika Lewińska, Pedro M. Rodrigues, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 12, pp. 748-766
Closed Access | Times Cited: 198
Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Dan Ye, Kun‐Liang Guan, Yue Xiong
Trends in cancer (2018) Vol. 4, Iss. 2, pp. 151-165
Open Access | Times Cited: 196
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Renumathy Dhanasekaran, Jean‐Charles Nault, Lewis R. Roberts, et al.
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 492-509
Open Access | Times Cited: 178
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Qianfei Zhang, Chi Ma, Yi Duan, et al.
Cancer Discovery (2020) Vol. 11, Iss. 5, pp. 1248-1267
Open Access | Times Cited: 177
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma
Man‐Hsin Hung, Joo Sang Lee, Chi Ma, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 162
Biomarkers for Hepatobiliary Cancers
Jean‐Charles Nault, Augusto Villanueva
Hepatology (2020) Vol. 73, Iss. S1, pp. 115-127
Closed Access | Times Cited: 147
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 99
Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer
Lichun Ma, S. Heinrich, Limin Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 95
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 92
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 90
Page 1 - Next Page

Scroll to top